Novel gene drives development of different types of ovarian cancer

March 27, 2013

Researchers at Mayo Clinic Cancer Center have identified a novel gene that can contribute to a woman's susceptibility for developing ovarian cancer. Researchers identified the gene, called HNF1B, through large-scale analysis of more than 16,000 women with ovarian cancer and more than 26,000 healthy women. Results of the study are published in the current issue of the journal Nature Communications.

The study is one of 13 papers to be published simultaneously in five journals by the Collaborative Oncological Gene-environment Study (COGS), an international research collaboration involving investigators from Europe, Asia, Australia and North America, including Mayo Clinic. This landmark series of papers provides genotyping results from more than 250,000 individuals that look at involved in three hormone-related cancers: ovarian, breast and prostate.

"Through the combined efforts of this consortium, and all the data sharing, we are much closer to understanding the inherited factors in these diseases," says Mayo Clinic investigator Ellen Goode, Ph.D., senior author of the HNF1B paper, and co-author of three additional papers among the 13, focusing on ovarian and breast . Ovarian cancer is the most common cause of death from in the U.S.

In their study, Dr. Goode and her collaborators showed that variations in the HNF1B gene are overrepresented in one type of epithelial ovarian cancer and underrepresented in another type. They also found that variation in , a process that moderates the expression of genes such as HNF1B, correlates with different ovarian cancer subtypes. This finding suggests that the activation and inhibition of gene expression by DNA methylation can be as important a factor in cancer as .

"The distinct methylation patterns suggest a molecular mechanism by which changes in this gene lead to increased cancer risk," says Dr. Goode. "This has potential clinical implications for improving our understanding of how the disease begins, for better identification of ovarian cancer subtypes and for developing novel treatment approaches."

Explore further: Five genetic variations increase risk of ovarian cancer

Related Stories

Five genetic variations increase risk of ovarian cancer

March 27, 2013

An international research collaboration has found five new regions of the human genome that are linked to increased risks for developing ovarian cancer. Duke Medicine researchers played a leading role analyzing genetic information ...

Role of known cancer gene in ovarian cancer investigated

February 14, 2012

The role of a known cancer-causing gene in the development of the most lethal type of ovarian cancer is being investigated by researchers from the Walter and Eliza Hall Institute after they were awarded a Cure Cancer Australia ...

Faulty gene connected to ovarian cancer risk

August 9, 2011

In a new study published in Nature Genetics researchers say that women who possess a fault in a gene named RAD51D have a greater risk of developing ovarian cancer than women who do not have this fault and tests are expected ...

Recommended for you

Cancer's big data problem

October 20, 2016

Data is pouring into the hands of cancer researchers, thanks to improvements in imaging, models and understanding of genetics. Today the data from a single patient's tumor in a clinical trial can add up to one terabyte—the ...

Gene fusions can lead to glioblastoma in children

October 20, 2016

Every year, about 60 children and adolescents in Germany are diagnosed with glioblastoma, a very aggressive type of brain cancer, which is still mostly untreatable. Now, scientists from the Max Planck Institute for Molecular ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.